Skip to main content

Table 2 Secondary study outcome measures Clinical endpoints

From: The combined diabetes and renal control trial (C-DIRECT) - a feasibility randomised controlled trial to evaluate outcomes in multi-morbid patients with diabetes and on dialysis using a mixed methods approach

  C-DIRECT Control
Variable Baseline Follow up Mean diff Baseline Follow up Mean Diff
M (SD) M (SD) M (SD) M (SD) M (SD) M (SD)
Potassium 4.67 (0.61) 4.67 (0.88) 0 (0.56) 4.61 (0.54) 4.80 (0.67) 0.20 (0.50)
Calcium 9.30 (0.68) 9.06 (0.63) −0.24 (0.72) 9.48 (0.48) 9.52 (0.46) 0.04 (0.52)
Phosphate 4.50 (1.11) 4.700 (1.15) 0.20 (1.43) 4.44 (1.06) 4.32 (1.23) −0.12 (0.95)
Haemoglobin 11.29 (1.37) 11.25 (1.31) −0.04 (1.42) 11.56 (1.24) 11.38 (0.92) −0.19 (0.81)
HbA1c (%) 9.57 (1.37) 8.78 (1.54) −0.80 (1.24)* 9.62 (1.40) 9.50 (2.05) −0.13 (1.10)*
Albumin 39.00 (2.75) 38.75 (2.79) −0.25 (1.80) 37.75 (2.75) 37.83 (2.91) 0.08 (1.67)
Interdialytic Weight Gain 3.71 (1.24) 3.41 (1.43) −0.30 (1.01) 3.43 (1.77) 3.52 (1.48) 0.09 (1.46)
  1. *significant main effect of time observed